A clinical trial combining megakaryocytes and haematopoietic stem cells to promote engraftment after autologous transplantation.

Helene Trebeden-NegreSylvain ChoquetMarie-Laure TanguyMichelle RozenzwajgNabih AzarFrancois LefrèreFarhad HeshmatiRamdane BelhocineVincent VieillardFrancoise Norol

Published in: British journal of haematology (2017)

Keyphrases

stem cells
cell therapy
clinical trial
phase ii
open label
bone marrow
hematopoietic stem cell
study protocol
double blind
mesenchymal stem cells
phase iii
platelet rich plasma
randomized controlled trial